CD52 and cerebral cavernous malformation: On the other hand, CD5-2 also significantly inhibited CCM depletion–induced inflammation evidenced by decreased ICAM-1 and NF-κB activation in vitro and reduced ICAM expression and numbers of CD11b+–expressing inflammatory cells associated with lesions.